Inicio › Cáncer de próstata › Kansas
Ensayos clínicos de Cáncer de próstata en Kansas
21 estudios sobre Cáncer de próstata buscan participantes en Kansas.
Ciudades en Kansas
- Kansas City12 estudios
- Topeka7 estudios
- Overland Park6 estudios
- Olathe5 estudios
- Lawrence3 estudios
- Pittsburg3 estudios
- Wichita3 estudios
Texto oficial del estudio (inglés)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Central Care Cancer Center - Garden City, Garden City
- Mercy Hospital Pittsburg, Pittsburg
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 13 nov 2026 · NCT04423211Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- y 4 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03866382Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Kansas University Cancer Center, Kansas City
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 5 nov 2026 · NCT07745361Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Veteran Administration Eastern Kansas Healthcare, Leavenworth
- y 4 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- University of Kansas Cancer Center, Kansas City
- The University of Kansas Cancer Center - Olathe, Olathe
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- y 2 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06632977Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- y 4 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT06931340A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- University of Kansas Medical Center, Kansas City
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 2 nov 2026 · NCT07581184Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- University of Kansas Cancer Center, Kansas City
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- y 3 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 23 oct 2026 · NCT05946213A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Kansas Medical Center, Westwood
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 20 oct 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- University of Kansas Hospital, Kansas City
ReclutandoFase 3
Edades de 18 a 100 · Hombres · Actualizado el 15 oct 2026 · NCT06855277Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- University of Kansas Cancer Center, Kansas City
- Olathe Health Cancer Center, Olathe
- University of Kansas Cancer Center-Overland Park, Overland Park
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 8 oct 2026 · NCT03678025DESTINY-PANTUMOUR04
- Research Site, Topeka
ReclutandoEstudio observacional
Edades de 18 a 130 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07124000Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- University of Kansas Hospital, Kansas City
ReclutandoFase 2/3
Edades de 18 a 100 · Hombres · Actualizado el 22 sept 2026 · NCT06780670Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Wichita Urology Group, Wichita
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 11 sept 2026 · NCT06056830PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
- University of Kansas Medical Center, Kansas City
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 22 jul 2026 · NCT06274047HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
- University of Kansas Health System, Kansas City
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 jul 2026 · NCT03802851Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Instititute - South, Overland Park
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699TERPS Trial for de Novo Oligometastic Prostate Cancer
- KU Medical Center- Cancer Center, Kansas City
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 3 jun 2026 · NCT05223803Study of AZD0754 in Participants With Metastatic Prostate Cancer
- Research Site, Westwood
ReclutandoFase 1/2
Edades de 18 a 130 · Hombres · Actualizado el 23 feb 2026 · NCT06267729A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Wichita Urology Group, Wichita
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 4 feb 2026 · NCT04729114Vitamin D for Prostate Endocrine Therapy
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Health System Saint Francis Campus, Topeka
- y 1 más
ReclutandoFase 3
Edades de 50 en adelante · Hombres · Actualizado el 15 ene 2026 · NCT05838716De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.